ribavirin has been researched along with Anemia, Fanconi in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keck, JL; Manthei, KA; Voter, AF | 1 |
| Flisiak, R; Lapiński, TW; Parfieniuk-Kowerda, A; Rogalska-Płońska, M | 1 |
2 other study(ies) available for ribavirin and Anemia, Fanconi
| Article | Year |
|---|---|
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
Topics: Antineoplastic Agents; DNA Damage; DNA Helicases; DNA Repair; Drug Screening Assays, Antitumor; Fanconi Anemia; High-Throughput Screening Assays; Humans; Multiprotein Complexes; Protein Interaction Maps; RecQ Helicases | 2016 |
Treatment of chronic hepatitis C in a patient with Fanconi anaemia.
Topics: Adult; Fanconi Anemia; Female; Genotype; Granulocyte Colony-Stimulating Factor; Hepatitis C, Chronic; Humans; Interferon-alpha; Phenotype; Ribavirin; Risk; Time Factors; Treatment Outcome; Viral Load | 2011 |